For which adverse effect does the nurse monitor in a patient taking hydroxyzine?

  • amiodarone

    hydroxyzine increases toxicity of amiodarone by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.

  • amisulpride

    amisulpride and hydroxyzine both increase QTc interval. Avoid or Use Alternate Drug. ECG monitoring is recommended if coadministered.

  • anagrelide

    hydroxyzine and anagrelide both increase QTc interval. Avoid or Use Alternate Drug.

  • arsenic trioxide

    hydroxyzine and arsenic trioxide both increase QTc interval. Avoid or Use Alternate Drug.

  • artemether

    artemether and hydroxyzine both increase QTc interval. Avoid or Use Alternate Drug.

  • artemether/lumefantrine

    artemether/lumefantrine and hydroxyzine both increase QTc interval. Avoid or Use Alternate Drug.

  • asenapine

    hydroxyzine and asenapine both increase QTc interval. Avoid or Use Alternate Drug.

  • asenapine transdermal

    asenapine transdermal and hydroxyzine both increase QTc interval. Avoid or Use Alternate Drug.

  • bedaquiline

    bedaquiline and hydroxyzine both increase QTc interval. Avoid or Use Alternate Drug.

  • calcium/magnesium/potassium/sodium oxybates

    hydroxyzine, calcium/magnesium/potassium/sodium oxybates. Either increases effects of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Profound sedation, respiratory depression, coma, and death may result if coadministered. Reserve concomitant prescribing of these drugs in patients for whom other treatment options are inadequate. Limit dosages and durations to the minimum required. Monitor closely for signs of respiratory depression and sedation.

  • ceritinib

    ceritinib and hydroxyzine both increase QTc interval. Avoid or Use Alternate Drug.

  • chloroquine

    chloroquine and hydroxyzine both increase QTc interval. Avoid or Use Alternate Drug.

  • citalopram

    hydroxyzine increases toxicity of citalopram by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.

  • clozapine

    hydroxyzine increases toxicity of clozapine by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.

  • crizotinib

    crizotinib and hydroxyzine both increase QTc interval. Avoid or Use Alternate Drug.

  • desflurane

    desflurane and hydroxyzine both increase QTc interval. Avoid or Use Alternate Drug.

  • disopyramide

    hydroxyzine and disopyramide both increase QTc interval. Avoid or Use Alternate Drug.

  • dofetilide

    hydroxyzine and dofetilide both increase QTc interval. Avoid or Use Alternate Drug.

  • droperidol

    hydroxyzine increases toxicity of droperidol by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.

  • eluxadoline

    hydroxyzine, eluxadoline. Either increases effects of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Avoid coadministration with other drugs that cause constipation. Increases risk for constipation related serious adverse reactions.

  • encorafenib

    encorafenib and hydroxyzine both increase QTc interval. Avoid or Use Alternate Drug.

  • entrectinib

    entrectinib and hydroxyzine both increase QTc interval. Avoid or Use Alternate Drug.

  • eribulin

    eribulin and hydroxyzine both increase QTc interval. Avoid or Use Alternate Drug.

  • fexinidazole

    fexinidazole and hydroxyzine both increase QTc interval. Avoid or Use Alternate Drug. Avoid coadministration of fexinidazole with drugs known to block potassium channels or prolong QT interval.

  • flecainide

    hydroxyzine and flecainide both increase QTc interval. Avoid or Use Alternate Drug.

  • fluoxetine

    hydroxyzine increases toxicity of fluoxetine by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.

  • foscarnet

    hydroxyzine and foscarnet both increase QTc interval. Avoid or Use Alternate Drug.

  • glasdegib

    hydroxyzine and glasdegib both increase QTc interval. Avoid or Use Alternate Drug.

  • hydroxychloroquine sulfate

    hydroxyzine and hydroxychloroquine sulfate both increase QTc interval. Avoid or Use Alternate Drug.

  • ibutilide

    hydroxyzine and ibutilide both increase QTc interval. Avoid or Use Alternate Drug.

  • iloperidone

    hydroxyzine increases toxicity of iloperidone by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.

  • isocarboxazid

    isocarboxazid increases effects of hydroxyzine by Other (see comment). Avoid or Use Alternate Drug. Comment: Isocarboxazid should not be administered in combination with antihistamines because of potential additive CNS depressant effects. MAO inhibitors also prolong and intensify anticholinergic effects of antihistamines. .

  • isoflurane

    hydroxyzine and isoflurane both increase QTc interval. Avoid or Use Alternate Drug.

  • lefamulin

    lefamulin and hydroxyzine both increase QTc interval. Avoid or Use Alternate Drug.

  • lenvatinib

    hydroxyzine and lenvatinib both increase QTc interval. Avoid or Use Alternate Drug.

  • lofexidine

    hydroxyzine and lofexidine both increase QTc interval. Avoid or Use Alternate Drug.

  • lopinavir

    hydroxyzine and lopinavir both increase QTc interval. Avoid or Use Alternate Drug.

  • macimorelin

    hydroxyzine and macimorelin both increase QTc interval. Avoid or Use Alternate Drug.

  • metoclopramide intranasal

    hydroxyzine, metoclopramide intranasal. Either increases effects of the other by Other (see comment). Avoid or Use Alternate Drug. Comment: Avoid use of metoclopramide intranasal or interacting drug, depending on importance of drug to patient.

  • midostaurin

    hydroxyzine and midostaurin both increase QTc interval. Avoid or Use Alternate Drug.

  • mifepristone

    hydroxyzine and mifepristone both increase QTc interval. Avoid or Use Alternate Drug.

  • mobocertinib

    hydroxyzine and mobocertinib both increase QTc interval. Avoid or Use Alternate Drug.

  • nilotinib

    hydroxyzine and nilotinib both increase QTc interval. Avoid or Use Alternate Drug.

  • olopatadine intranasal

    hydroxyzine and olopatadine intranasal both increase sedation. Avoid or Use Alternate Drug. Coadministration increases risk of CNS depression, which can lead to additive impairment of psychomotor performance and cause daytime impairment.

  • osimertinib

    hydroxyzine and osimertinib both increase QTc interval. Avoid or Use Alternate Drug.

  • oxaliplatin

    hydroxyzine and oxaliplatin both increase QTc interval. Avoid or Use Alternate Drug.

  • ozanimod

    hydroxyzine and ozanimod both increase QTc interval. Avoid or Use Alternate Drug.

  • paliperidone

    hydroxyzine and paliperidone both increase QTc interval. Avoid or Use Alternate Drug.

  • panobinostat

    hydroxyzine and panobinostat both increase QTc interval. Avoid or Use Alternate Drug.

  • pazopanib

    hydroxyzine and pazopanib both increase QTc interval. Avoid or Use Alternate Drug.

  • pimavanserin

    hydroxyzine and pimavanserin both increase QTc interval. Avoid or Use Alternate Drug.

  • pimozide

    hydroxyzine and pimozide both increase QTc interval. Contraindicated.

  • pitolisant

    hydroxyzine decreases effects of pitolisant by Other (see comment). Avoid or Use Alternate Drug. Comment: Pitolisant increases histamine levels in the brain; therefore, H1 receptor antagonists that cross the blood-brain barrier may reduce the efficacy of pitolisant.hydroxyzine and pitolisant both increase QTc interval. Avoid or Use Alternate Drug.

  • ponesimod

    hydroxyzine and ponesimod both increase QTc interval. Avoid or Use Alternate Drug.

  • procainamide

    hydroxyzine increases toxicity of procainamide by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.

  • propafenone

    hydroxyzine and propafenone both increase QTc interval. Avoid or Use Alternate Drug.

  • quetiapine

    hydroxyzine increases toxicity of quetiapine by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.

  • quinidine

    hydroxyzine increases toxicity of quinidine by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.

  • quinine

    hydroxyzine and quinine both increase QTc interval. Avoid or Use Alternate Drug.

  • ribociclib

    hydroxyzine and ribociclib both increase QTc interval. Avoid or Use Alternate Drug.

  • saquinavir

    hydroxyzine and saquinavir both increase QTc interval. Avoid or Use Alternate Drug.

  • selpercatinib

    hydroxyzine and selpercatinib both increase QTc interval. Avoid or Use Alternate Drug.

  • sevoflurane

    hydroxyzine and sevoflurane both increase QTc interval. Avoid or Use Alternate Drug.

  • siponimod

    hydroxyzine and siponimod both increase QTc interval. Avoid or Use Alternate Drug.

  • sodium oxybate

    hydroxyzine, sodium oxybate. Either increases effects of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Profound sedation, respiratory depression, coma, and death may result if coadministered. Reserve concomitant prescribing of these drugs in patients for whom other treatment options are inadequate. Limit dosages and durations to the minimum required. Monitor closely for signs of respiratory depression and sedation.

  • sorafenib

    hydroxyzine and sorafenib both increase QTc interval. Avoid or Use Alternate Drug.

  • sotalol

    hydroxyzine increases toxicity of sotalol by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.

  • tetrabenazine

    hydroxyzine and tetrabenazine both increase QTc interval. Avoid or Use Alternate Drug.

  • toremifene

    hydroxyzine and toremifene both increase QTc interval. Avoid or Use Alternate Drug.

  • tranylcypromine

    tranylcypromine increases effects of hydroxyzine by Other (see comment). Avoid or Use Alternate Drug. Comment: Tranylcypromine should not be administered in combination with antihistamines because of potential additive CNS depressant effects. MAO inhibitors also prolong and intensify anticholinergic effects of antihistamines.

  • trazodone

    hydroxyzine and trazodone both increase QTc interval. Avoid or Use Alternate Drug.

  • vandetanib

    hydroxyzine and vandetanib both increase QTc interval. Avoid or Use Alternate Drug.

  • vemurafenib

    hydroxyzine and vemurafenib both increase QTc interval. Avoid or Use Alternate Drug.

  • ziprasidone

    hydroxyzine increases toxicity of ziprasidone by QTc interval. Avoid or Use Alternate Drug. Increases risk of torsades de pointes.

  • albuterol

    hydroxyzine increases and albuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.albuterol and hydroxyzine both increase QTc interval. Use Caution/Monitor.

  • alfentanil

    hydroxyzine and alfentanil both increase sedation. Use Caution/Monitor.

  • alfuzosin

    alfuzosin and hydroxyzine both increase QTc interval. Use Caution/Monitor.

  • alprazolam

    hydroxyzine and alprazolam both increase sedation. Use Caution/Monitor.

  • amifampridine

    hydroxyzine increases toxicity of amifampridine by Other (see comment). Modify Therapy/Monitor Closely. Comment: Amifampridine can cause seizures. Coadministration with drugs that lower seizure threshold may increase this risk.

  • amitriptyline

    hydroxyzine and amitriptyline both increase sedation. Use Caution/Monitor.hydroxyzine and amitriptyline both increase QTc interval. Use Caution/Monitor.

  • amobarbital

    hydroxyzine and amobarbital both increase sedation. Use Caution/Monitor.

  • amoxapine

    hydroxyzine and amoxapine both increase sedation. Use Caution/Monitor.

  • apomorphine

    hydroxyzine and apomorphine both increase sedation. Use Caution/Monitor.apomorphine and hydroxyzine both increase QTc interval. Use Caution/Monitor.

  • arformoterol

    hydroxyzine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.arformoterol and hydroxyzine both increase QTc interval. Use Caution/Monitor.

  • aripiprazole

    hydroxyzine and aripiprazole both increase sedation. Use Caution/Monitor.aripiprazole and hydroxyzine both increase QTc interval. Use Caution/Monitor.

  • armodafinil

    hydroxyzine increases and armodafinil decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • atomoxetine

    atomoxetine and hydroxyzine both increase QTc interval. Use Caution/Monitor.

  • azelastine

    azelastine and hydroxyzine both increase sedation. Use Caution/Monitor.

  • azithromycin

    hydroxyzine increases toxicity of azithromycin by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes.

  • baclofen

    hydroxyzine and baclofen both increase sedation. Use Caution/Monitor.

  • belladonna and opium

    hydroxyzine and belladonna and opium both increase sedation. Use Caution/Monitor.

  • benperidol

    hydroxyzine and benperidol both increase sedation. Use Caution/Monitor.

  • benzphetamine

    hydroxyzine increases and benzphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • brexanolone

    brexanolone, hydroxyzine. Either increases toxicity of the other by sedation. Use Caution/Monitor.

  • brompheniramine

    brompheniramine and hydroxyzine both increase sedation. Use Caution/Monitor.

  • buprenorphine

    hydroxyzine and buprenorphine both increase sedation. Use Caution/Monitor.hydroxyzine and buprenorphine both increase QTc interval. Modify Therapy/Monitor Closely. If coadministration necessary, consider consider dose reduction of one or both drugs due to potential for additive pharmacological effects

  • buprenorphine buccal

    hydroxyzine and buprenorphine buccal both increase sedation. Use Caution/Monitor.

  • butabarbital

    hydroxyzine and butabarbital both increase sedation. Use Caution/Monitor.

  • butalbital

    hydroxyzine and butalbital both increase sedation. Use Caution/Monitor.

  • butorphanol

    hydroxyzine and butorphanol both increase sedation. Use Caution/Monitor.

  • caffeine

    hydroxyzine increases and caffeine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • carbinoxamine

    carbinoxamine and hydroxyzine both increase sedation. Use Caution/Monitor.

  • carisoprodol

    hydroxyzine and carisoprodol both increase sedation. Use Caution/Monitor.

  • chloral hydrate

    hydroxyzine and chloral hydrate both increase sedation. Use Caution/Monitor.

  • chlordiazepoxide

    hydroxyzine and chlordiazepoxide both increase sedation. Use Caution/Monitor.

  • chlorpheniramine

    chlorpheniramine and hydroxyzine both increase sedation. Use Caution/Monitor.

  • chlorpromazine

    hydroxyzine and chlorpromazine both increase sedation. Use Caution/Monitor.hydroxyzine increases toxicity of chlorpromazine by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes.

  • chlorzoxazone

    hydroxyzine and chlorzoxazone both increase sedation. Use Caution/Monitor.

  • cinnarizine

    cinnarizine and hydroxyzine both increase sedation. Use Caution/Monitor.

  • ciprofloxacin

    hydroxyzine and ciprofloxacin both increase QTc interval. Use Caution/Monitor.

  • clarithromycin

    hydroxyzine increases toxicity of clarithromycin by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes.

  • clemastine

    clemastine and hydroxyzine both increase sedation. Use Caution/Monitor.

  • clobazam

    hydroxyzine, clobazam. Other (see comment). Use Caution/Monitor. Comment: Concomitant administration can increase the potential for CNS effects (e.g., increased sedation or respiratory depression).

  • clomipramine

    hydroxyzine and clomipramine both increase sedation. Use Caution/Monitor.hydroxyzine and clomipramine both increase QTc interval. Use Caution/Monitor.

  • clonazepam

    hydroxyzine and clonazepam both increase sedation. Use Caution/Monitor.

  • clonidine

    clonidine, hydroxyzine. Either increases toxicity of the other by pharmacodynamic synergism. Use Caution/Monitor. Coadministration enhances CNS depressant effects.

  • clorazepate

    hydroxyzine and clorazepate both increase sedation. Use Caution/Monitor.

  • clozapine

    hydroxyzine and clozapine both increase sedation. Use Caution/Monitor.

  • codeine

    hydroxyzine and codeine both increase sedation. Use Caution/Monitor.

  • cyclizine

    cyclizine and hydroxyzine both increase sedation. Use Caution/Monitor.

  • cyclobenzaprine

    hydroxyzine and cyclobenzaprine both increase sedation. Use Caution/Monitor.

  • cyproheptadine

    cyproheptadine and hydroxyzine both increase sedation. Use Caution/Monitor.

  • dantrolene

    hydroxyzine and dantrolene both increase sedation. Use Caution/Monitor.

  • daridorexant

    hydroxyzine and daridorexant both increase sedation. Modify Therapy/Monitor Closely. Coadministration increases risk of CNS depression, which can lead to additive impairment of psychomotor performance and cause daytime impairment.

  • dasatinib

    dasatinib and hydroxyzine both increase QTc interval. Use Caution/Monitor.

  • degarelix

    degarelix and hydroxyzine both increase QTc interval. Use Caution/Monitor.

  • desflurane

    desflurane and hydroxyzine both increase sedation. Use Caution/Monitor.

  • desipramine

    hydroxyzine and desipramine both increase sedation. Use Caution/Monitor.hydroxyzine and desipramine both increase QTc interval. Use Caution/Monitor.

  • deutetrabenazine

    hydroxyzine and deutetrabenazine both increase sedation. Use Caution/Monitor.deutetrabenazine and hydroxyzine both increase QTc interval. Use Caution/Monitor. At the maximum recommended dose, deutetrabenazine does not prolong QT interval to a clinically relevant extent. Certain circumstances may increase risk of torsade de pointes and/or sudden death in association with drugs that prolong the QTc interval (eg, bradycardia, hypokalemia or hypomagnesemia, coadministration with other drugs that prolong QTc interval, presence of congenital QT prolongation).

  • dexchlorpheniramine

    dexchlorpheniramine and hydroxyzine both increase sedation. Use Caution/Monitor.

  • dexfenfluramine

    hydroxyzine increases and dexfenfluramine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • dexmedetomidine

    hydroxyzine and dexmedetomidine both increase sedation. Use Caution/Monitor.

  • dexmethylphenidate

    hydroxyzine increases and dexmethylphenidate decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • dextroamphetamine

    hydroxyzine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • dextromoramide

    hydroxyzine and dextromoramide both increase sedation. Use Caution/Monitor.

  • diamorphine

    hydroxyzine and diamorphine both increase sedation. Use Caution/Monitor.

  • diazepam

    hydroxyzine and diazepam both increase sedation. Use Caution/Monitor.

  • diazepam intranasal

    diazepam intranasal, hydroxyzine. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Coadministration may potentiate the CNS-depressant effects of each drug.

  • diethylpropion

    hydroxyzine increases and diethylpropion decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • difelikefalin

    difelikefalin and hydroxyzine both increase sedation. Use Caution/Monitor.

  • difenoxin hcl

    hydroxyzine and difenoxin hcl both increase sedation. Use Caution/Monitor.

  • dimenhydrinate

    dimenhydrinate and hydroxyzine both increase sedation. Use Caution/Monitor.

  • diphenhydramine

    diphenhydramine and hydroxyzine both increase sedation. Use Caution/Monitor.

  • diphenoxylate hcl

    hydroxyzine and diphenoxylate hcl both increase sedation. Use Caution/Monitor.

  • dipipanone

    hydroxyzine and dipipanone both increase sedation. Use Caution/Monitor.

  • dobutamine

    hydroxyzine increases and dobutamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • dolasetron

    dolasetron and hydroxyzine both increase QTc interval. Use Caution/Monitor.

  • donepezil

    donepezil and hydroxyzine both increase QTc interval. Use Caution/Monitor.

  • donepezil transdermal

    donepezil transdermal, hydroxyzine. Either decreases effects of the other by pharmacodynamic antagonism. Use Caution/Monitor.

  • dopamine

    hydroxyzine increases and dopamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • dopexamine

    hydroxyzine increases and dopexamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • dosulepin

    hydroxyzine and dosulepin both increase sedation. Use Caution/Monitor.

  • doxepin

    hydroxyzine and doxepin both increase sedation. Use Caution/Monitor.doxepin and hydroxyzine both increase QTc interval. Use Caution/Monitor.

  • doxylamine

    hydroxyzine and doxylamine both increase sedation. Use Caution/Monitor.

  • droperidol

    hydroxyzine and droperidol both increase sedation. Use Caution/Monitor.

  • efavirenz

    efavirenz and hydroxyzine both increase QTc interval. Use Caution/Monitor.

  • eliglustat

    hydroxyzine and eliglustat both increase QTc interval. Use Caution/Monitor.

  • ephedrine

    hydroxyzine increases and ephedrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • epinephrine

    hydroxyzine increases and epinephrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • epinephrine racemic

    hydroxyzine increases and epinephrine racemic decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • erythromycin base

    hydroxyzine increases toxicity of erythromycin base by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes.

  • erythromycin ethylsuccinate

    hydroxyzine increases toxicity of erythromycin ethylsuccinate by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes.

  • erythromycin lactobionate

    hydroxyzine increases toxicity of erythromycin lactobionate by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes.

  • erythromycin stearate

    hydroxyzine increases toxicity of erythromycin stearate by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes.

  • escitalopram

    hydroxyzine and escitalopram both increase QTc interval. Use Caution/Monitor.

  • esketamine intranasal

    esketamine intranasal, hydroxyzine. Either increases toxicity of the other by sedation. Modify Therapy/Monitor Closely.

  • estazolam

    hydroxyzine and estazolam both increase sedation. Use Caution/Monitor.

  • ethanol

    hydroxyzine and ethanol both increase sedation. Use Caution/Monitor.

  • etomidate

    etomidate and hydroxyzine both increase sedation. Use Caution/Monitor.

  • ezogabine

    hydroxyzine and ezogabine both increase QTc interval. Use Caution/Monitor. Slight and transient QT-prolongation observed, particularly when dose titrated to 1200mg/day. QT interval should be monitored when ezogabine is prescribed with agents known to increase QT interval.

  • fenfluramine

    hydroxyzine increases and fenfluramine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • fentanyl

    fentanyl, hydroxyzine. Either increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of fentanyl with anticholinergics may increase risk for urinary retention and/or severe constipation, which may lead to paralytic ileus.

  • fentanyl intranasal

    fentanyl intranasal, hydroxyzine. Either increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of fentanyl with anticholinergics may increase risk for urinary retention and/or severe constipation, which may lead to paralytic ileus.

  • fentanyl transdermal

    fentanyl transdermal, hydroxyzine. Either increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of fentanyl with anticholinergics may increase risk for urinary retention and/or severe constipation, which may lead to paralytic ileus.

  • fentanyl transmucosal

    fentanyl transmucosal, hydroxyzine. Either increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of fentanyl with anticholinergics may increase risk for urinary retention and/or severe constipation, which may lead to paralytic ileus.

  • fingolimod

    fingolimod and hydroxyzine both increase QTc interval. Use Caution/Monitor.

  • flibanserin

    hydroxyzine and flibanserin both increase sedation. Modify Therapy/Monitor Closely. Risk for sedation increased if flibanserin is coadministration with other CNS depressants.

  • fluconazole

    hydroxyzine and fluconazole both increase QTc interval. Use Caution/Monitor.

  • fluphenazine

    hydroxyzine and fluphenazine both increase sedation. Use Caution/Monitor.hydroxyzine and fluphenazine both increase QTc interval. Use Caution/Monitor.

  • flurazepam

    hydroxyzine and flurazepam both increase sedation. Use Caution/Monitor.

  • fluvoxamine

    hydroxyzine and fluvoxamine both increase QTc interval. Use Caution/Monitor.

  • formoterol

    hydroxyzine increases and formoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • fostemsavir

    hydroxyzine and fostemsavir both increase QTc interval. Use Caution/Monitor. QTc prolongation reported with higher than recommended doses of fostemsavir.

  • gabapentin

    gabapentin, hydroxyzine. Either increases effects of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of CNS depressants can result in serious, life-threatening, and fatal respiratory depression. Use lowest dose possible and monitor for respiratory depression and sedation.

  • gabapentin enacarbil

    gabapentin enacarbil, hydroxyzine. Either increases effects of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of CNS depressants can result in serious, life-threatening, and fatal respiratory depression. Use lowest dose possible and monitor for respiratory depression and sedation.

  • ganaxolone

    hydroxyzine and ganaxolone both increase sedation. Use Caution/Monitor.

  • gemifloxacin

    gemifloxacin and hydroxyzine both increase QTc interval. Use Caution/Monitor.

  • gemtuzumab

    hydroxyzine and gemtuzumab both increase QTc interval. Use Caution/Monitor.

  • gilteritinib

    gilteritinib and hydroxyzine both increase QTc interval. Use Caution/Monitor.

  • glycopyrronium tosylate topical

    glycopyrronium tosylate topical, hydroxyzine. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Coadministration of glycopyrronium tosylate topical with other anticholinergic medications may result in additive anticholinergic adverse effects.

  • goserelin

    hydroxyzine and goserelin both increase QTc interval. Use Caution/Monitor.

  • gotu kola

    gotu kola increases effects of hydroxyzine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression.

  • granisetron

    granisetron and hydroxyzine both increase QTc interval. Use Caution/Monitor.

  • haloperidol

    hydroxyzine and haloperidol both increase sedation. Use Caution/Monitor.hydroxyzine and haloperidol both increase QTc interval. Use Caution/Monitor.

  • hawthorn

    hawthorn increases effects of hydroxyzine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression.

  • histrelin

    hydroxyzine and histrelin both increase QTc interval. Use Caution/Monitor.

  • hops

    hops increases effects of hydroxyzine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression.

  • hyaluronidase

    hydroxyzine decreases effects of hyaluronidase by Other (see comment). Use Caution/Monitor. Comment: Antihistamines, when given in large systemic doses, may render tissues partially resistant to the action of hyaluronidase. Patients may require larger amounts of hyaluronidase for equivalent dispersing effect.

  • hydromorphone

    hydroxyzine and hydromorphone both increase sedation. Use Caution/Monitor.

  • iloperidone

    hydroxyzine and iloperidone both increase sedation. Use Caution/Monitor.

  • imipramine

    hydroxyzine and imipramine both increase sedation. Use Caution/Monitor.hydroxyzine and imipramine both increase QTc interval. Use Caution/Monitor.

  • inotuzumab

    hydroxyzine and inotuzumab both increase QTc interval. Modify Therapy/Monitor Closely. If coadministration necessary, obtain baseline ECG to assess initial QT interval and determine frequency of subsequent monitoring; avoid non-essential QT prolonging drug and correct electrolyte imbalances

  • isoproterenol

    hydroxyzine increases and isoproterenol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • itraconazole

    hydroxyzine and itraconazole both increase QTc interval. Use Caution/Monitor.itraconazole and hydroxyzine both increase QTc interval. Use Caution/Monitor.

  • ivosidenib

    hydroxyzine and ivosidenib both decrease QTc interval. Modify Therapy/Monitor Closely. If coadministration necessary, obtain baseline ECG to assess initial QT interval and determine frequency of subsequent monitoring; avoid non-essential QT prolonging drug and correct electrolyte imbalances

  • kava

    kava increases effects of hydroxyzine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression.

  • ketamine

    ketamine and hydroxyzine both increase sedation. Use Caution/Monitor.

  • ketotifen, ophthalmic

    hydroxyzine and ketotifen, ophthalmic both increase sedation. Use Caution/Monitor.

  • lapatinib

    hydroxyzine and lapatinib both increase QTc interval. Use Caution/Monitor.

  • lasmiditan

    lasmiditan, hydroxyzine. Either increases effects of the other by sedation. Use Caution/Monitor. Coadministration of lasmiditan and other CNS depressant drugs, including alcohol have not been evaluated in clinical studies. Lasmiditan may cause sedation, as well as other cognitive and/or neuropsychiatric adverse reactions.

  • lemborexant

    lemborexant, hydroxyzine. Either increases effects of the other by sedation. Modify Therapy/Monitor Closely. Dosage adjustment may be necessary if lemborexant is coadministered with other CNS depressants because of potentially additive effects.

  • leuprolide

    hydroxyzine and leuprolide both increase QTc interval. Use Caution/Monitor.

  • levalbuterol

    hydroxyzine increases and levalbuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • levofloxacin

    hydroxyzine and levofloxacin both increase QTc interval. Use Caution/Monitor.

  • levorphanol

    hydroxyzine and levorphanol both increase sedation. Use Caution/Monitor.

  • lisdexamfetamine

    hydroxyzine increases and lisdexamfetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • lithium

    hydroxyzine and lithium both increase QTc interval. Use Caution/Monitor.

  • lofepramine

    hydroxyzine and lofepramine both increase sedation. Use Caution/Monitor.

  • lofexidine

    hydroxyzine and lofexidine both increase sedation. Use Caution/Monitor.

  • loperamide

    hydroxyzine and loperamide both increase QTc interval. Use Caution/Monitor.

  • loprazolam

    hydroxyzine and loprazolam both increase sedation. Use Caution/Monitor.

  • lorazepam

    hydroxyzine and lorazepam both increase sedation. Use Caution/Monitor.

  • lormetazepam

    hydroxyzine and lormetazepam both increase sedation. Use Caution/Monitor.

  • loxapine

    hydroxyzine and loxapine both increase sedation. Use Caution/Monitor.

  • loxapine inhaled

    hydroxyzine and loxapine inhaled both increase sedation. Use Caution/Monitor.

  • lurasidone

    lurasidone, hydroxyzine. Either increases toxicity of the other by Other (see comment). Use Caution/Monitor. Comment: Potential for increased CNS depressant effects when used concurrently; monitor for increased adverse effects and toxicity.

  • maprotiline

    hydroxyzine and maprotiline both increase sedation. Use Caution/Monitor.hydroxyzine and maprotiline both increase QTc interval. Use Caution/Monitor.

  • marijuana

    hydroxyzine and marijuana both increase sedation. Use Caution/Monitor.

  • mefloquine

    hydroxyzine and mefloquine both increase QTc interval. Use Caution/Monitor.

  • melatonin

    hydroxyzine and melatonin both increase sedation. Use Caution/Monitor.

  • meperidine

    hydroxyzine and meperidine both increase sedation. Use Caution/Monitor.

  • meprobamate

    hydroxyzine and meprobamate both increase sedation. Use Caution/Monitor.

  • metaproterenol

    hydroxyzine increases and metaproterenol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • metaxalone

    hydroxyzine and metaxalone both increase sedation. Use Caution/Monitor.

  • methadone

    hydroxyzine and methadone both increase sedation. Use Caution/Monitor.hydroxyzine increases toxicity of methadone by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes.

  • methamphetamine

    hydroxyzine increases and methamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • methocarbamol

    hydroxyzine and methocarbamol both increase sedation. Use Caution/Monitor.

  • methylenedioxymethamphetamine

    hydroxyzine increases and methylenedioxymethamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • midazolam

    hydroxyzine and midazolam both increase sedation. Use Caution/Monitor.

  • midazolam intranasal

    midazolam intranasal, hydroxyzine. Either increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Concomitant use of barbiturates, alcohol, or other CNS depressants may increase the risk of hypoventilation, airway obstruction, desaturation, or apnea and may contribute to profound and/or prolonged drug effect.

  • midodrine

    hydroxyzine increases and midodrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • mirtazapine

    hydroxyzine and mirtazapine both increase sedation. Use Caution/Monitor.hydroxyzine and mirtazapine both increase QTc interval. Use Caution/Monitor.

  • modafinil

    hydroxyzine increases and modafinil decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • morphine

    hydroxyzine and morphine both increase sedation. Use Caution/Monitor.

  • motherwort

    hydroxyzine and motherwort both increase sedation. Use Caution/Monitor.

  • moxifloxacin

    hydroxyzine increases toxicity of moxifloxacin by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes.

  • moxonidine

    hydroxyzine and moxonidine both increase sedation. Use Caution/Monitor.

  • nabilone

    hydroxyzine and nabilone both increase sedation. Use Caution/Monitor.

  • nalbuphine

    hydroxyzine and nalbuphine both increase sedation. Use Caution/Monitor.

  • norepinephrine

    hydroxyzine increases and norepinephrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • nortriptyline

    hydroxyzine and nortriptyline both increase sedation. Use Caution/Monitor.hydroxyzine and nortriptyline both increase QTc interval. Use Caution/Monitor.

  • octreotide

    hydroxyzine and octreotide both increase QTc interval. Use Caution/Monitor.

  • ofloxacin

    hydroxyzine and ofloxacin both increase QTc interval. Use Caution/Monitor.

  • olanzapine

    hydroxyzine and olanzapine both increase sedation. Use Caution/Monitor.hydroxyzine and olanzapine both increase QTc interval. Use Caution/Monitor. Limited data, including some case reports, suggest that olanzapine may be associated with a significant prolongation of the QTc interval in rare instances

  • ondansetron

    hydroxyzine increases toxicity of ondansetron by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes.

  • opium tincture

    hydroxyzine and opium tincture both increase sedation. Use Caution/Monitor.

  • orphenadrine

    hydroxyzine and orphenadrine both increase sedation. Use Caution/Monitor.

  • osilodrostat

    osilodrostat and hydroxyzine both increase QTc interval. Use Caution/Monitor.

  • oxazepam

    hydroxyzine and oxazepam both increase sedation. Use Caution/Monitor.

  • oxycodone

    hydroxyzine and oxycodone both increase sedation. Use Caution/Monitor.

  • oxymorphone

    hydroxyzine and oxymorphone both increase sedation. Use Caution/Monitor.

  • paliperidone

    hydroxyzine and paliperidone both increase sedation. Use Caution/Monitor.

  • papaveretum

    hydroxyzine and papaveretum both increase sedation. Use Caution/Monitor.

  • papaverine

    hydroxyzine and papaverine both increase sedation. Use Caution/Monitor.

  • paroxetine

    hydroxyzine and paroxetine both increase QTc interval. Use Caution/Monitor.

  • pasireotide

    hydroxyzine and pasireotide both increase QTc interval. Use Caution/Monitor.

  • passion flower

    passion flower increases effects of hydroxyzine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression.

  • pentamidine

    hydroxyzine increases toxicity of pentamidine by QTc interval. Use Caution/Monitor. Increases risk of torsades de pointes.

  • pentazocine

    hydroxyzine and pentazocine both increase sedation. Use Caution/Monitor.

  • pentobarbital

    hydroxyzine and pentobarbital both increase sedation. Use Caution/Monitor.

  • perampanel

    perampanel and hydroxyzine both increase sedation. Use Caution/Monitor.

  • perphenazine

    hydroxyzine and perphenazine both increase sedation. Use Caution/Monitor.hydroxyzine and perphenazine both increase QTc interval. Use Caution/Monitor.

  • phendimetrazine

    hydroxyzine increases and phendimetrazine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • phenelzine

    phenelzine increases effects of hydroxyzine by Other (see comment). Modify Therapy/Monitor Closely. Comment: Coadministration of phenelzine and antihistamines may result in additive CNS depressant effects. MAO inhibitors also prolong and intensify anticholinergic effects of antihistamines. .

  • phenobarbital

    hydroxyzine and phenobarbital both increase sedation. Use Caution/Monitor.

  • phentermine

    hydroxyzine increases and phentermine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • phenylephrine

    hydroxyzine increases and phenylephrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • phenylephrine PO

    hydroxyzine increases and phenylephrine PO decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor. .

  • pholcodine

    hydroxyzine and pholcodine both increase sedation. Use Caution/Monitor.

  • pimozide

    hydroxyzine and pimozide both increase sedation. Use Caution/Monitor.

  • pirbuterol

    hydroxyzine increases and pirbuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • posaconazole

    hydroxyzine and posaconazole both increase QTc interval. Use Caution/Monitor.

  • pregabalin

    pregabalin, hydroxyzine. Either increases effects of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of CNS depressants can result in serious, life-threatening, and fatal respiratory depression. Use lowest dose possible and monitor for respiratory depression and sedation.

  • primaquine

    hydroxyzine and primaquine both increase QTc interval. Use Caution/Monitor.

  • primidone

    hydroxyzine and primidone both increase sedation. Use Caution/Monitor.

  • prochlorperazine

    hydroxyzine and prochlorperazine both increase sedation. Use Caution/Monitor.hydroxyzine and prochlorperazine both decrease QTc interval. Use Caution/Monitor.

  • promethazine

    hydroxyzine and promethazine both increase sedation. Use Caution/Monitor.hydroxyzine and promethazine both decrease QTc interval. Use Caution/Monitor.

  • propofol

    propofol and hydroxyzine both increase sedation. Use Caution/Monitor.

  • propylhexedrine

    hydroxyzine increases and propylhexedrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • protriptyline

    hydroxyzine and protriptyline both increase sedation. Use Caution/Monitor.hydroxyzine and protriptyline both increase QTc interval. Use Caution/Monitor.

  • quazepam

    hydroxyzine and quazepam both increase sedation. Use Caution/Monitor.

  • quetiapine

    hydroxyzine and quetiapine both increase sedation. Use Caution/Monitor.

  • ramelteon

    hydroxyzine and ramelteon both increase sedation. Use Caution/Monitor.

  • ranolazine

    hydroxyzine and ranolazine both increase QTc interval. Use Caution/Monitor.

  • rilpivirine

    hydroxyzine and rilpivirine both increase QTc interval. Use Caution/Monitor.

  • risperidone

    hydroxyzine and risperidone both increase sedation. Use Caution/Monitor.hydroxyzine and risperidone both increase QTc interval. Use Caution/Monitor.

  • romidepsin

    hydroxyzine and romidepsin both increase QTc interval. Use Caution/Monitor.

  • salmeterol

    hydroxyzine increases and salmeterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • scullcap

    hydroxyzine and scullcap both increase sedation. Use Caution/Monitor.

  • secobarbital

    hydroxyzine and secobarbital both increase sedation. Use Caution/Monitor.

  • sertraline

    hydroxyzine and sertraline both increase QTc interval. Use Caution/Monitor.

  • sevoflurane

    sevoflurane and hydroxyzine both increase sedation. Use Caution/Monitor.

  • shepherd's purse

    hydroxyzine and shepherd's purse both increase sedation. Use Caution/Monitor.

  • solifenacin

    hydroxyzine and solifenacin both increase QTc interval. Use Caution/Monitor.

  • stiripentol

    stiripentol, hydroxyzine. Either increases effects of the other by sedation. Use Caution/Monitor. Concomitant use stiripentol with other CNS depressants, including alcohol, may increase the risk of sedation and somnolence.

  • sufentanil

    hydroxyzine and sufentanil both increase sedation. Use Caution/Monitor.

  • sunitinib

    hydroxyzine and sunitinib both increase QTc interval. Use Caution/Monitor.

  • tacrolimus

    hydroxyzine and tacrolimus both increase QTc interval. Use Caution/Monitor.

  • tapentadol

    hydroxyzine and tapentadol both increase sedation. Use Caution/Monitor.

  • telavancin

    hydroxyzine and telavancin both increase QTc interval. Use Caution/Monitor.

  • temazepam

    hydroxyzine and temazepam both increase sedation. Use Caution/Monitor.

  • terbutaline

    hydroxyzine increases and terbutaline decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • thioridazine

    hydroxyzine and thioridazine both increase sedation. Use Caution/Monitor.

  • thiothixene

    hydroxyzine and thiothixene both increase sedation. Use Caution/Monitor.

  • topiramate

    hydroxyzine and topiramate both increase sedation. Modify Therapy/Monitor Closely.

  • tramadol

    hydroxyzine and tramadol both increase sedation. Use Caution/Monitor.

  • trazodone

    hydroxyzine and trazodone both increase sedation. Use Caution/Monitor.

  • triazolam

    hydroxyzine and triazolam both increase sedation. Use Caution/Monitor.

  • triclabendazole

    hydroxyzine and triclabendazole both increase QTc interval. Use Caution/Monitor.

  • triclofos

    hydroxyzine and triclofos both increase sedation. Use Caution/Monitor.

  • trifluoperazine

    hydroxyzine and trifluoperazine both increase sedation. Use Caution/Monitor.hydroxyzine and trifluoperazine both decrease QTc interval. Use Caution/Monitor.

  • trimipramine

    hydroxyzine and trimipramine both increase sedation. Use Caution/Monitor.hydroxyzine and trimipramine both increase QTc interval. Use Caution/Monitor.

  • triprolidine

    hydroxyzine and triprolidine both increase sedation. Use Caution/Monitor.

  • triptorelin

    hydroxyzine and triptorelin both increase QTc interval. Use Caution/Monitor.

  • valbenazine

    valbenazine and hydroxyzine both increase QTc interval. Use Caution/Monitor.

  • valerian

    valerian increases effects of hydroxyzine by pharmacodynamic synergism. Use Caution/Monitor. May enhance CNS depression.

  • vardenafil

    hydroxyzine and vardenafil both increase QTc interval. Use Caution/Monitor.

  • venlafaxine

    hydroxyzine and venlafaxine both decrease QTc interval. Use Caution/Monitor.

  • voclosporin

    hydroxyzine and voclosporin both increase QTc interval. Use Caution/Monitor.

  • vorinostat

    hydroxyzine and vorinostat both increase QTc interval. Use Caution/Monitor.

  • xylometazoline

    hydroxyzine increases and xylometazoline decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • yohimbine

    hydroxyzine increases and yohimbine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.

  • ziconotide

    hydroxyzine and ziconotide both increase sedation. Use Caution/Monitor.

  • ziprasidone

    hydroxyzine and ziprasidone both increase sedation. Use Caution/Monitor.

  • zotepine

    hydroxyzine and zotepine both increase sedation. Use Caution/Monitor.

  • What are the side effects of taking hydroxyzine?

    Side Effects.
    Chest pain, discomfort, or tightness..
    difficulty with swallowing..
    fast heartbeat..
    hives, itching, or skin rash..
    irregular or slow heart rate..
    puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue..
    trouble breathing..

    What are the nursing implications of hydroxyzine?

    Summary of Use during Lactation Larger doses or more prolonged use may cause drowsiness and other effects in the infant or decrease the milk supply, particularly in combination with a sympathomimetic such as pseudoephedrine or before lactation is well established.

    Does hydroxyzine cause liver damage?

    Despite widespread use, hydroxyzine has not been linked to liver test abnormalities or to clinically apparent liver injury.

    Does hydroxyzine affect blood pressure?

    Minor side effects were only observed in the hydroxyzine group. Changes in blood pressure were more pronounced in the hydroxyzine group.